1. Home
  2. HTBK vs XERS Comparison

HTBK vs XERS Comparison

Compare HTBK & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • XERS
  • Stock Information
  • Founded
  • HTBK 1997
  • XERS 2005
  • Country
  • HTBK United States
  • XERS United States
  • Employees
  • HTBK N/A
  • XERS N/A
  • Industry
  • HTBK Major Banks
  • XERS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • XERS Health Care
  • Exchange
  • HTBK Nasdaq
  • XERS Nasdaq
  • Market Cap
  • HTBK 588.2M
  • XERS 727.1M
  • IPO Year
  • HTBK 1998
  • XERS 2018
  • Fundamental
  • Price
  • HTBK $10.24
  • XERS $4.63
  • Analyst Decision
  • HTBK Buy
  • XERS Strong Buy
  • Analyst Count
  • HTBK 3
  • XERS 6
  • Target Price
  • HTBK $11.33
  • XERS $6.25
  • AVG Volume (30 Days)
  • HTBK 482.2K
  • XERS 2.2M
  • Earning Date
  • HTBK 07-24-2025
  • XERS 08-07-2025
  • Dividend Yield
  • HTBK 5.08%
  • XERS N/A
  • EPS Growth
  • HTBK N/A
  • XERS N/A
  • EPS
  • HTBK 0.68
  • XERS N/A
  • Revenue
  • HTBK $174,083,000.00
  • XERS $222,551,000.00
  • Revenue This Year
  • HTBK $7.71
  • XERS $35.03
  • Revenue Next Year
  • HTBK $6.13
  • XERS $18.31
  • P/E Ratio
  • HTBK $15.06
  • XERS N/A
  • Revenue Growth
  • HTBK N/A
  • XERS 29.88
  • 52 Week Low
  • HTBK $8.09
  • XERS $2.03
  • 52 Week High
  • HTBK $11.27
  • XERS $6.07
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 72.82
  • XERS 50.34
  • Support Level
  • HTBK $9.11
  • XERS $4.59
  • Resistance Level
  • HTBK $9.81
  • XERS $4.90
  • Average True Range (ATR)
  • HTBK 0.19
  • XERS 0.18
  • MACD
  • HTBK 0.07
  • XERS 0.02
  • Stochastic Oscillator
  • HTBK 91.86
  • XERS 56.67

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Share on Social Networks: